The UK Government is set to add an additional £160m to the Cancer Drugs Fund, in order to improve treatment for patients.

The funding is intended to increase the grant from £200m a year to £280m annually over the next two years.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The fund is confirmed until March 2016, following an extension in 2013.

NHS England cancer experts said that two new drugs will be added to the fund, Xtandi (enzalutamide) for prostate cancer and Revlimid (lenalidomide) for patients with myelodysplastic syndrome, a rare blood condition.

"It’s vitally important that as many people as possible have access to these pioneering, life-enhancing drugs."

UK Health Secretary Jeremy Hunt said: "It’s vitally important that as many people as possible have access to these pioneering, life-enhancing drugs, and we need to continue to focus our efforts on increasing access to these innovative treatments, whilst ensuring that all patients continue to receive the effective drugs, which are right for them.

See Also:

The fund has been used to treat around 55,000 cancer patients, since it was set up four years ago to provide drugs for the people who need them most.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It has a crucial role in helping patients to access treatment, as the number of people diagnosed with cancer is seen increasing ever year by 9% in the country.

NHS England also plans to negotiate with pharmaceutical industry to offer best price on drugs, as well as working with NICE, researchers and patient charities to evaluate wider process for commissioning decisions on new cancer drugs.

The government has prepared £750m cancer strategy to improve cancer survival rates and provide better treatment.